Mirae Asset Tiger China Biotech Solactive ETF (KRX:371470)
9,535.00
+185.00 (1.98%)
At close: Sep 12, 2025
1.98% (1Y)
Assets | 73.16B |
Expense Ratio | 0.49% |
PE Ratio | 37.01 |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Ex-Dividend Date | n/a |
Payout Frequency | n/a |
Payout Ratio | n/a |
1-Year Return | +99.27% |
Volume | 271,070 |
Open | 9,390.00 |
Previous Close | 9,350.00 |
Day's Range | 9,390.00 - 9,610.00 |
52-Week Low | 4,745.00 |
52-Week High | 9,960.00 |
Beta | 0.14 |
Holdings | 10 |
Inception Date | Dec 3, 2020 |
About 371470
This ETF seeks to replicate the daily performance of the SOLACTIVE China Biotech Index by investing in China,Hong Kong listed equity.or ADR
Asset Class Equity
Category Health Care
Stock Exchange Korea Stock Exchange
Ticker Symbol 371470
Provider Tiger ETF
Index Tracked Solactive China Biotech Index
Performance
371470 had a total return of 99.27% in the past year, including dividends. Since the fund's inception, the average annual return has been -0.99%.
Top 10 Holdings
74.00% of assetsName | Symbol | Weight |
---|---|---|
Solactive China Biotech Index Cnh Trs 250207-02 | n/a | 21.09% |
WuXi Biologics (Cayman) Inc. | 2269 | 6.93% |
Repo(매수)-20250917 | n/a | 6.82% |
WuXi AppTec Co., Ltd. | 2359 | 6.63% |
Global X China Biotech ETF | 2820 | 6.38% |
BeOne Medicines AG | ONC | 6.21% |
Jiangsu Hengrui Medicine Co., Ltd. | 600276 | 5.80% |
Innovent Biologics, Inc. | 1801 | 5.71% |
Solactive China Biotech Index Cnh Trs 250207-03 | n/a | 4.48% |
Sino Biopharmaceutical Limited | 1177 | 3.94% |